Hollister Biosciences Closes Transformational Acquisition of Rapidly Growing Venom Extracts Adding Over $16.4 Million In 2019 Revenue and $2.5 Million in EBITDA

This highly accretive acquisition strengthens Hollister's brand portfolio and broadens its distribution footprint across multiple states positioning Hollister to transform into an industry leader in 2020 and beyond VANCOUVER, March 30, 2020 /PRNewswire/ - Hollister Biosciences Inc. (CSE:...

from PR Newswire: https://ift.tt/2UJkY8R